Policies for Biodefense Revisited: The Prioritized Vaccination Process for Smallpox
dc.contributor.author | Kress, Moshe | |
dc.date | 2005-05 | |
dc.date.accessioned | 2014-01-09T22:21:56Z | |
dc.date.available | 2014-01-09T22:21:56Z | |
dc.date.issued | 2005-05 | |
dc.identifier.citation | 2006 “Policies for Biodefense Revisited: The Prioritized Vaccination Process for Smallpox”, Annals of Operations Research, 148, pp 5-23 | |
dc.identifier.uri | https://hdl.handle.net/10945/38153 | |
dc.description | Annals of Operations Research, 148, pp 5-23 | en_US |
dc.description.abstract | Handling bioierror events that involve contagious agents is a major concern in the war against terror, and is a cause for debate among policymakers about the best response policy. At the core of this debate stands the question which of the post-event policies to adopt: mass vaccination--where maximum vaccination capacity is utilized to uniformly inoculate the entire population, or trace (also called ring or targeted) vaccination--where mass vaccinations capabilities are ttaded off with tracing capabilities to selectively inoculate only contacts (or suspected contacts) of infective individuals. We present a dynamic epidemic-intervention model that expands previous models by capturing some additional key features of the situation and by generalizing some assumptions regarding the probability distributions of inter-temporal parameters. The model comprises a set of difference equations. The model is implemented to analyze alternative response policies. It is shown that a mixture of mass and trace vaccination policies--the prioritized vaccination policy--is more effective that either of the two aforementioned policies. | en_US |
dc.rights | defined in Title 17, United States Code, Section 101. Copyright protection is not available for this work in the United States. | en_US |
dc.title | Policies for Biodefense Revisited: The Prioritized Vaccination Process for Smallpox | en_US |
dc.type | Article | en_US |
dc.contributor.department | Operations Research (OR) | |
dc.subject.author | mass vaccination | en_US |
dc.subject.author | trace vaccination | en_US |
dc.subject.author | prioritized vaccination | en_US |
dc.subject.author | potentially traceable | en_US |